IPO

The iGaming supplier launches 80 exclusive games in Brazil's new regulated market, a strategic move to capture growth in Latin America's largest economy.

Riding a wave of record sales from its iDose TR implant, Glaukos is set to update investors on its explosive growth and the launch of its new drug, Epioxa.

In a show of strong investor confidence, Gilat secured an oversubscribed $100M private placement, fueling its strategy for major acquisitions in the satcom market.

Southchip posts its 11th straight quarter of revenue growth, but falling margins and a huge R&D spend reveal a bold, high-risk expansion strategy.

A new energy storage system just passed an unprecedented fire test, raising safety standards and building trust in the technology powering our future.

A new office for Lexington Partners reveals Abu Dhabi's rise as a global finance hub and the growing demand for complex liquidity solutions in private markets.

After bombshell allegations and a stock plunge, Rezolve AI faces a major lawsuit investigation, raising critical questions about AI hype and corporate honesty.

Bluerock is listing its private real estate fund on the NYSE, offering monthly payouts. Is this a game-changer for retail investors or a risky strategic play?

A decade-long wait ends as the FDA approves a new 1st-line therapy for HER2+ breast cancer. See how ENHERTU reshapes patient outcomes and market dynamics.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

Varsity Healthcare Partners' new foundation applies investment-grade rigor to its giving, funding charities with measurable health and wellness impacts.

New rankings name Germany's top cancer hospitals, but the real story is the rise of platforms shaping a multi-billion dollar global health market.

Klarna is moving beyond payments to build the data layer for AI shopping. Will its new open protocol revolutionize retail or just shift the balance of power?

As cargo theft surges, one company’s AI-powered security is becoming the new standard for protecting the nation’s vital logistics and its drivers.

An Indiana biotech prepares for biotech's biggest stage, showcasing a pipeline that offers new hope for chronic endocrine and metabolic disorders.

AMTD Digital's subsidiary is on a global hotel buying binge, but a history of extreme stock volatility and underlying financial risks raise serious questions.

A new FDA clearance for its AI software enhances Hyperfine's portable MRI, positioning it to disrupt the lucrative stroke diagnostics market. Here's why.

With a dual listing on Brazil's B3 exchange, DeFi Technologies isn't just expanding—it's building a strategic blueprint for institutional crypto adoption.

With a massive $129M capital injection, Almonty Industries is set to break China's grip on tungsten, a metal critical for defense and technology.

A public fund's major investment in Consensys, the firm behind MetaMask, signals growing institutional confidence in Web3's foundational infrastructure.